Harnessing the Endogenous Melanocortin System to Resolve IBD – A New Paradigm to Treat Inflammatory Diseases
Time: 9:00 am
day: Conference Day Two
Details:
- Biasing tissue and immune cells towards resolving inflammation
- Unprecedented safety by employing the natural mode of resolution removes efficacy/ toxicity balance considerations
- Exploring the need for and type of patient stratification biomarkers
